North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market Share

Statistics for the 2023 & 2024 North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) market share, created by Mordor Intelligence™ Industry Reports. North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Hyperglycemics Research North America Sodium-Glucose Cotransporter Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Industry

The market studied is consolidated with Janssen Pharmaceutical, Eli Lilly, AstraZeneca Pharmaceuticals, and Boehringer Ingelheim Pharmaceuticals holding a high market share, followed by regional manufacturers accounting for a relatively smaller share.

North America SGLT2 Market Leaders

  1. Janssen Pharmaceutical

  2. Eli Lilly

  3. AstraZeneca Pharmaceuticals

  4. Boehringer Ingelheim Pharmaceuticals

  5. Astellas

*Disclaimer: Major Players sorted in no particular order

North America Sodium-Dependent Glucose Co-Transporter 2 (Sglt2) Market Concentration

North America SGLT2 Market Report Snapshots

North America SGLT2 Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)